11AWriting of prescriptions‑prescriptions other than medication chart prescriptions

11A  Writing of prescriptions‑prescriptions other than medication chart prescriptions

 (1) An RPBS prescriber writes a prescription in accordance with this Scheme if the RPBS prescriber :

 (a) prepares the prescription:

 (i) in duplicate, by handwriting the prescription in ink on a prescription form:

 (A) that is as nearly as practicable 18 centimetres long by 12 centimetres wide; and

 (B) on which appears the name and address of the RPBS prescriber and, subject to subsection (4), the letters ‘RPBS’(or ‘DVA’); and

 (C) on the original of which appear the words ‘pharmacist/patient copy’; and

 (D) on the duplicate of which appear the words ‘Medicare Australia/DVA copy’; or

 (ii) in duplicate, by means of a computer on a prescription form:

 (A) that is as nearly as practicable 18 centimetres long by 12 centimetres wide; and

 (B) on which appears the name and address of the RPBS prescriber and, subject to subsection (4), the letters ‘RPBS’ (or ‘DVA’); and

 (C) on the original of which appear the words ‘pharmacist/patient copy’; and

 (D) on the duplicate of which appear the words ‘Medicare Australia/DVA copy’; and

 (E) that is approved in writing for the purpose by the Secretary (as defined in the National Health Act 1953); or

 (iia) by means of a form:

 (A) on which appear the name and address of the RPBS prescriber and the letters ‘RPBS’ (or ‘DVA’); and

 (B) that is approved in writing by the Secretary (as defined in the National Health Act 1953) for the purpose of writing an electronic prescription; or

 (iii)  by another method approved in writing by the Secretary (as defined in the National Health Act 1953); and

 (b) signs the prescription after it is prepared; and

 (c) for an authority prescription—writes on it that prior approval has been obtained (if the case); and

 (d) specifies on the prescription the date on which the prescription is written; and

 (e) for a Authorised Midwife or Authorised Nurse Practitioner—states in the prescription the number allotted to his or her approval under section 16 of the National Health (Pharmaceutical Benefits) Regulations 2017; and

 (f) states in the prescription the name of the person for whom the Pharmaceutical benefit is prescribed and the address of that person; and

 (g) identifies in the prescription the Pharmaceutical benefit in accordance with subsection (1A); and

 (h) states in the prescription:

 (i) the quantity or number of units of the Pharmaceutical benefit to be supplied; and